[1]
ahmed F. al_talkani and S. H. Kathem, “The Prevalence of UGT1A1*93 and ABCC5 Polymorphisms in Cancer Patients Receiving Irinotecan-Based Chemotherapy at Al-Najaf Al-Ashraf”, Iraqi Journal of Pharmaceutical Sciences , vol. 28, no. 2, pp. 24–29, Dec. 2019, doi: 10.31351/vol28iss2pp24-29.